Eoin recently finished a Masters in E-business in UCC and received a 1st class honors. ONCOassist™ developed as part of his master’s project with Kevin Bambury.
Since then Eoin has been developing and refining the application to the needs of the Oncologists and has been increasing his knowledge of the medical app market and other business skill sets.
Prior to this he worked as a Civil Engineer where he developed a large organizational skill base, which was key in the completion of high pressure, time constraint projects.
Kevin recently graduated from the Masters of Electronic Business in UCC with a 1st class honours degree.
He has previous experience working in start-ups as the co-founder of Dingadeal.com and having worked with Sigojoven.com in Spain. He worked with AIB in Brand Management and marketing focusing on the area of sponsorships. He managed AIBs sponsorship of the GAA club championships in 2007.
Prior to this he studied a BA in English and Geography and a Higher Diploma in Management and Marketing.
Richard is a medical oncologist at Memorial Sloan Kettering Cancer Center in NYC. He is heavily involved in patient care and academic research.
He is the recipient of numerous awards including the the Ainsworth Scholarship from UCC in 2012, the John Quale Travel fellowship in 2013 and is a lead co-investigator on a Prostate Cancer Foundation-Movember Challenge Award worth $1 million in 2014.
In his career to date he has presented over 40 original research abstracts at national and international oncology conferences including ESMO, ASCO and ASCO GU. His work has been published in peer reviewed journals including the New England Journal of Medicine. He is dedicated to improving cancer patient care through ongoing innovation and research.
Jeff McBride is a subject matter expert in Software Quality Assurance and Regulatory Affairs for the medical technologies and healthcare sectors. He has worked in this area for over 30 years and is an acknowledged key opinion leader in ensuring that Software Development is completed in a compliant manner.
In addition, he has actively worked with start up medical technology companies to ensure that research carried out in this area can be successfully transitioned into the commercial environment without the need to revalidate research work.